Skip to content

Evaluation The Effect Of Amalaki Beeja Churna In Asrigdara

Clinical Evaluation Of Amalaki Beeja Churna In Asrigdara W.S.R To Dysfunctional Uterine Bleeding - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095155
Enrollment
30
Registered
2025-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Sponsors

Rishikul Campus Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married and unmarried females Females having Chief complaint of excessive bleeding Per vaginum during menses either in amount or duration or both or during short inter menstrual period for 3 consecutive cycles Patients having normal BMI Hb more than 8 gm per dl

Exclusion criteria

Exclusion criteria: Patients having systemic diseases like Hypertension, Diabetes Mellitus, Tuberculosis, Thyroid dysfunction, Blood Coagulopathies Women of Penmenopausal & Postmenopausal age Pregnant women, Post partum females Patient having H/O recent Abortion Patient suffering from DUB complicated by non-responding Anemia Patient having organic pathology like Cervical or Uterine Polyp, Uterine Fibroids, PID Patients using OCP (Oral Contraceptive Pills), IUCD (Intra Uterine Contraceptive Device) or taking hormonal treatment

Design outcomes

Primary

MeasureTime frame
Reduction In Amount Of Heavy BleedingTimepoint: 2 Month

Secondary

MeasureTime frame
Significant Improvement In Associated Symptoms Like Lower Backache & Generalised WeaknessTimepoint: 1 Month

Countries

India

Contacts

Public ContactAradhana Gupta

Rishikul Campus Haridwar

dr.kavyajain@gmail.com9902345121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026